---
title: "3B Films Ltd (544412) — Share Price, Financials & Analysis"
symbol: "544412"
company: "3B Films Ltd"
canonical: "https://tapetide.com/stocks/544412"
isin: "INE0TE101010"
nse_symbol: "3BFILMSLTD"
bse_code: "544412"
sector: "Industrial Products"
industry: "Packaging"
market_cap_cr: 33.46
generated_at: "2026-09-13T19:40:14.361Z"
---

# 3B Films Ltd (544412)

Canonical page: https://tapetide.com/stocks/544412

## Company

- **NSE Symbol:** 3BFILMSLTD
- **BSE Code:** 544412
- **ISIN:** INE0TE101010
- **Sector:** Industrial Products
- **Industry:** Packaging
- **Macro Sector:** Industrials
- **Stock Type:** EQUITY
- **Listed Since:** 2025-06-06
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** 3bfilms.com

## About

Incorporated in 2014, 3B Films Ltd is in the business of manufacturing and supplying CPP & CPE films.[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:40:24.047240Z.

- **Market Cap:** ₹33.46 Cr
- **Classification:** SME
- **P/E (reported):** 19.1
- **Book Value:** ₹21.47
- **Price to Book:** 0.66
- **Dividend Yield:** 0%
- **ROE:** 3.47%
- **ROCE:** 5.69%
- **Debt to Equity:** 1.89
- **Revenue (yearly):** ₹62 Cr
- **Net Income:** ₹1.8 Cr
- **EBITDA:** ₹13.1 Cr
- **52-Week High:** ₹36.49
- **52-Week Low:** ₹11
- **RSI (14):** 54.4

## Tapetide Score

- **Score:** 38 / 100
- **Score date:** 2026-09-04
- **Archetype:** Weak and Under Pressure
- **What it means:** Weak financials are the defining feature, and neither the valuation nor the trend reading is strong enough to offset them. Worth reading the risk flags and recent filings closely before anything else.
- **Pillar profile:** Quality: Weak · Valuation: Fair · Momentum: Falling
- **Percentile:** 10.2 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 20.51 | 9% |
| growth | 6.72 | 9% |
| momentum | 5.18 | 12% |
| ownership | 50 | 24% |
| quality | 46.06 | 22% |
| valuation | 54.34 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Stock is trading at 0.69 times its book value

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -0.93% over past five years.
- Tax rate seems low
- Company has a low return on equity of 12.2% over last 3 years.
- Company might be capitalizing the interest cost
- Company has high debtors of 201 days.
- Working capital days have increased from 131 days to 222 days

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -110.75% | -616.13% | -111.03% |
| ebitda margin growth | -35.19% | 10.67% | 2.73% | 68.61% |
| net income growth | -12.5% | -64.71% | 26% | 61% |
| revenue growth | 85.89% | -27.82% | -6% | -1% |
| roce | — | -48.78% | -52.94% | 8.67% |
| roe | — | -75.73% | 13.14% | -146.02% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Sales | 44.79 | 46.4 | 38.91 | 25.72 | 34.3 |
| Expenses | 36.61 | 37.75 | 31.79 | 22.17 | 26.82 |
| Operating Profit | 8.18 | 8.65 | 7.12 | 3.55 | 7.48 |
| OPM % | 18.26 | 18.64 | 18.3 | 13.8 | 21.81 |
| Other Income | 0.4 | 0.24 | 0.33 | 1.06 | 0.9 |
| Interest | 3.11 | 3.06 | 2.58 | 2.56 | 2.39 |
| Depreciation | 1.85 | 2.44 | 2.44 | 2.99 | 2.92 |
| Profit before tax | 3.62 | 3.39 | 2.43 | -0.94 | 3.07 |
| Tax % | 9.94 | 11.21 | 16.05 | 0 | 8.79 |
| Net Profit | 3.25 | 3.01 | 2.04 | -0.95 | 2.79 |
| EPS in Rs | 1.53 | 1.42 | 0.96 | -0.38 | 1.13 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 47.06 | 58.47 | 62.88 | 67.25 | 71.8 | 75.75 | 85.31 | 60.01 |
| Expenses | 43.82 | 51.97 | 55.83 | 59.26 | 61.89 | 60.74 | 69.55 | 48.93 |
| Operating Profit | 3.24 | 6.5 | 7.05 | 7.99 | 9.91 | 15.01 | 15.76 | 11.08 |
| OPM % | 6.88 | 11.12 | 11.21 | 11.88 | 13.8 | 19.82 | 18.47 | 18.46 |
| Other Income | 1.41 | 0.6 | 0.54 | 0.68 | 1.02 | 0.65 | 0.58 | 1.97 |
| Interest | 2.48 | 3.38 | 3.38 | 6.03 | 6.32 | 6.76 | 5.64 | 5.02 |
| Depreciation | 1.91 | 1.95 | 2.16 | 3.19 | 3.27 | 3.12 | 4.88 | 5.91 |
| Profit before tax | 0.26 | 1.77 | 2.05 | -0.55 | 1.34 | 5.78 | 5.82 | 2.12 |
| Tax % | 480.77 | 53.11 | 91.71 | -38.18 | 31.34 | 11.07 | 13.23 | 12.74 |
| Net Profit | -0.99 | 0.83 | 0.17 | -0.34 | 0.92 | 5.14 | 5.05 | 1.84 |
| EPS in Rs | -0.5 | 0.39 | 0.08 | -0.16 | 0.43 | 2.42 | 2.38 | 0.74 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 20 | 21.22 | 21.22 | 21.22 | 21.22 | 21.22 | 21.22 | 24.77 |
| Reserves | -11.58 | -1.96 | -1.79 | 4.49 | 5.41 | 2.55 | 14.1 | 28.41 |
| Borrowings | 52.8 | 48.04 | 86.03 | 99.34 | 98.56 | 106.55 | 102.48 | 100.46 |
| Other Liabilities | 9.73 | 11.29 | 13.14 | 7.12 | 8.85 | 14.69 | 24.98 | 26.75 |
| Total Liabilities | 70.95 | 78.59 | 118.6 | 132.17 | 134.04 | 145.01 | 162.78 | 180.39 |
| Fixed Assets | 47.08 | 46.13 | 86.66 | 83.84 | 81.4 | 81.26 | 82.02 | 83.56 |
| CWIP | 0 | 0.61 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 23.87 | 31.85 | 31.94 | 48.33 | 52.64 | 63.75 | 80.76 | 96.83 |
| Total Assets | 70.95 | 78.59 | 118.6 | 132.17 | 134.04 | 145.01 | 162.78 | 180.39 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | — | — | 14.51 | 1.49 | — | 0.31 | 14.89 | -1.6 |
| Cash from Investing Activity | — | — | -42.09 | -0.37 | — | -2.97 | -5.64 | -7.45 |
| Cash from Financing Activity | — | — | 27.26 | 1.26 | — | 2.67 | -9.71 | 8.98 |
| Net Cash Flow | — | — | -0.31 | 2.37 | — | 0.02 | -0.46 | -0.08 |
| Free Cash Flow | — | — | -27.58 | 1.12 | — | -2.66 | 9.25 | -9.05 |
| CFO/OP | — | — | 211 | 19 | — | 2 | 94 | -14 |

### Ratios

| Item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 55.46 | 39.76 | 39.3 | 30.94 | 21.81 | 46.06 | 87.58 | 201.26 |
| Inventory Days | 94.11 | 122.15 | 168.09 | 252.63 | 326.2 | 367.43 | 325.79 | 538.54 |
| Days Payable | 73.66 | 69.85 | 60.97 | 50.37 | 61.35 | 44.61 | 132.66 | 229.77 |
| Cash Conversion Cycle | 75.91 | 92.06 | 146.42 | 233.2 | 286.66 | 368.89 | 280.72 | 510.03 |
| Working Capital Days | 4.19 | 47.19 | 0 | 35.93 | 21.2 | 92.08 | 77.91 | 221.58 |
| ROCE % | — | 8.01 | 6.29 | 4.76 | 6.12 | 9.82 | 8.55 | 4.9 |

## Shareholding Pattern

### Quarterly

| Category | Jun 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- |
| Promoters | 69.97% | 69.97% | 69.97% |
| FIIs | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% |
| Government | 0% | 0% | 0% |
| Public | 28.24% | 29.27% | 29.32% |
| Others | 1.79% | 0.76% | 0.71% |
| No. of Shareholders | 1698 | 1236 | 1148 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Sell
- **Buy / Neutral / Sell:** 8 / 2 / 9

### Moving Averages — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 12.64 | Buy |
| EMA (10) | 13.25 | Buy |
| SMA (20) | 13.01 | Buy |
| EMA (20) | 13.37 | Buy |
| SMA (50) | 14.78 | Buy |
| EMA (50) | 14.94 | Sell |
| SMA (100) | 17.73 | Sell |
| EMA (100) | 17.2 | Sell |
| SMA (200) | 21.21 | Sell |
| EMA (200) | 21.48 | Sell |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 58.99 | Neutral |
| MACD (12,26,9) | -0.44 | Buy |
| Stochastic (14,3,3) | 89.22 | Sell |
| ADX (14) | 33.35 | Buy |
| Williams %R (14) | 0 | Sell |
| ATR (14) | 0.74 | High Volatility |
| ROC (12) | 15.02 | Buy |
| Stoch RSI (14) | 100 | Sell |
| UO (7,14,28) | 70.34 | Sell |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 7 May - Postal ballot passed appointing Nabil Ansari as Independent Non-Executive Director on May 7, 2026. | [Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot 7 May - Postal ballot passed appointing Nabil Ansari as Independent Non-Executive Director on May 7, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/7fa9b7d4-6a13-410d-b97f-68d66b159dd3.pdf) |
| 6h - Banwari Lal Mittal bought 5,000 shares on 18-02-2026; holding 1,07,51,603 (33.7989%). | [Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg, 2015 6h - Banwari Lal Mittal bought 5,000 shares on 18-02-2026; holding 1,07,51,603 (33.7989%).](https://www.bseindia.com/xml-data/corpfiling/AttachLive/0db39c45-b6d1-4b6b-89b5-20ba3f4f58fe.pdf) |
| 6 Mar - Company Secretary & Compliance Officer Urvi Pravin Poriya resigns effective March 10, 2026, citing personal reasons. | [Announcement under Regulation 30 (LODR)-Change in Management 6 Mar - Company Secretary & Compliance Officer Urvi Pravin Poriya resigns effective March 10, 2026, citing personal reasons.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d78e4830-ac05-4aaa-a2d4-6bf8e2387010.pdf) |
| 6 Apr - Mrs. Niki Tiwari appointed Company Secretary and Compliance Officer effective 6 April 2026. | [Announcement under Regulation 30 (LODR)-Change in Management 6 Apr - Mrs. Niki Tiwari appointed Company Secretary and Compliance Officer effective 6 April 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2a965ac7-a8e1-4323-a8b5-b016c8d6881e.pdf) |
| 6 Apr - Board met on 6 April 2026; noted resignation of CS, appointed new CS, and approved postal ballot. | [Board Meeting Outcome for Outcome Of Board Meeting 6 Apr - Board met on 6 April 2026; noted resignation of CS, appointed new CS, and approved postal ballot.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/28ead06e-b5c7-4d3a-89ce-5a3a6afc254a.pdf) |
| 30 Apr - 3B Films updated contact details of authorised KMPs for SEBI Regulation 30(5) disclosures. | [Disclosure under Regulation 30A of LODR 30 Apr - 3B Films updated contact details of authorised KMPs for SEBI Regulation 30(5) disclosures.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c4c22bea-39cc-41cb-a8db-1a36d5f7f6b1.pdf) |
| 30 Apr - 3B Films updated contact details of authorised KMPs for SEBI Regulation 30(5) disclosures. | [Disclosure under Regulation 30A of LODR 30 Apr - 3B Films updated contact details of authorised KMPs for SEBI Regulation 30(5) disclosures.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/c4c22bea-39cc-41cb-a8db-1a36d5f7f6b1.pdf) |
| 2m - Announcement under Reg 30 of SEBI (LODR) - Change in Name of the Company from Sastasundar Ventures Limited to Health X Platform Limited. | [Announcement under Regulation 30 (LODR)-Change of Company Name 2m - Announcement under Reg 30 of SEBI (LODR) - Change in Name of the Company from Sastasundar Ventures Limited to Health X Platform Limited.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/45698538-35ac-4463-925b-dc92d6984d62.pdf) |
| 2h - Board approved in‑principle merger of SHBL into HealthX; contingent on Mitsubishi sale to Envision (SPA dated 25-02-2026). | [Board Meeting Outcome for Disclosure Under Reg 30 Of SEBI (LODR) - Outcome Of Meeting Of The Board 2h - Board approved in‑principle merger of SHBL into HealthX; contingent on Mitsubishi sale to Envision (SPA dated 25-02-2026).](https://www.bseindia.com/xml-data/corpfiling/AttachLive/fcaf2b82-b676-4e99-9566-061e4bd3dac4.pdf) |
| 27 Feb - Tripartite Agreement: Envision acquires Mitsubishi's SHBL stake; scheme to merge SHBL into HealthX; Envision may get board seat. | [Disclosure under Regulation 30A of LODR 27 Feb - Tripartite Agreement: Envision acquires Mitsubishi's SHBL stake; scheme to merge SHBL into HealthX; Envision may get board seat.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/535eb430-032e-45b2-90d5-df70d84c1940.pdf) |

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-08-19 | [Intimation Regarding Change In Corporate Identification Number (CIN) Of The Company](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8f79488b-d92b-4c75-8160-410adc9b5ab6.pdf) |
| 2026-08-10 | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2570911B_64CE_43B9_BC99_43547E50701C_145053.pdf) |
| 2026-08-10 | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=099D5DCE_8458_478D_93D9_8E0B292A2857_145256.pdf) |
| 2026-08-10 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=04a77339-e6a5-4073-9084-c7470769c1b7.pdf) |
| 2026-08-08 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=74dca7d6-622f-4779-b134-30d6634947c5.pdf) |
| 2026-08-06 | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4253DAA3_C2C4_4240_9B4C_E8752A9B82BA_155325.pdf) |
| 2026-08-06 | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09BC3B51_E00A_43BB_B89B_1058D581291F_155411.pdf) |
| 2026-07-21 | [Intimation Regarding Change In Corporate Identification Number (CIN) Of The Company](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3f431b9f-abcf-48cd-acd6-b7fd534dd83a.pdf) |
| 2026-07-20 | [Intimation Under Regulation 36 Of The SEBI (LODR) Regulations 2015.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a2ad7f26-30bd-43f5-be1a-c31616d38de1.pdf) |
| 2026-07-17 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=47b19f2d-c947-4909-8e48-76060946a2be.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-05-30 | [Results - Financial Results For March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=23e7adb5-3b01-483b-9d1b-d2ec24c0a202.pdf) |
| 2025-11-13 | [Clarification In The Un-Audited Financial Result For The Half Year Ended On September 30 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=041e51d5-398b-4a3e-9e0c-19b30e888efc.pdf) |
| 2025-11-11 | [Revised Financial Result For The Half Year Ended On September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e86e32ed-16be-4b3e-acab-02642eaf9b73.pdf) |
| 2025-11-10 | [Un-Audited Financial Result As On September 30 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=03839133-a443-4ce2-ab07-874fe82e4d9f.pdf) |
| 2025-09-04 | [Results - Financial Results For Half Year And Year Ended March 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=34713272-767c-4ede-9355-2a629cab16bb.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Sep 2022 | [Concall - Sep 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c4ea8984-37b8-4d91-a69c-0ee9286cfc30.pdf) |
| Oct 2024 | [Concall - Oct 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f562d3d5-d2c0-42f8-a4b3-9d8913f197b0.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8af28204-77c6-4a3d-8790-3a1fa7344d38.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/982ad4db-ceb7-4606-9c7e-f74d0efb639f.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6ea1595c-128c-4222-9760-0abcd1b9db85.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/541c3044-e927-405e-9e2f-1c77ac738bc6.pdf) |
| Nov 2021 | [Concall - Nov 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4405952f-aa4e-4bcd-8e3d-de7b042217f2.pdf) |
| Nov 2021 | [Concall - Nov 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/797d26a0-aa4a-4158-b932-27212ab288e3.pdf) |
| Nov 2020 | [Concall - Nov 2020](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a45830a2-cd96-4c30-a94e-9f72d95daadd.pdf) |
| Nov 2017 | [Concall - Nov 2017](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2017/11/abd5103b-e675-4018-8c82-48e894e4cd09.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2013 from nse](https://archives.nseindia.com/annual_reports/AR_709_MICROSEC_2012_2013_23072013140010.zip) |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/47b19f2d-c947-4909-8e48-76060946a2be.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ee1ac65b-f02c-4df9-8efd-962e5c5a9c1b.pdf) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/07434f13-418d-4db6-bb03-f2d2a6dcf515.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/79a73ef8-b5b2-4d7e-b734-86bc22d4540a.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fe44cfe6-7cb3-45df-ab98-d816f120da72.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/533259/76611533259.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/533259/71176533259.pdf) |
| from bse | [Financial Year 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/533259/5332590320.pdf) |
| from bse | [Financial Year 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/533259/5332590319.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:40:14.361Z.